Quantinno Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.3M Sell
116,229
-11,696
-9% -$117K ﹤0.01% 2567
2026
Q2
$1.3M Buy
127,925
+31,998
+33% +$304K ﹤0.01% 2353
2026
Q1
$860K Buy
95,927
+56,655
+144% +$451K ﹤0.01% 2279
2025
Q4
$237K Buy
39,272
+16,391
+72% +$97.6K ﹤0.01% 2971
2025
Q3
$131K Buy
22,881
+44
+0.2% +$225 ﹤0.01% 2855
2025
Q2
$115K Buy
22,837
+4,129
+22% +$22.1K ﹤0.01% 2483
2025
Q1
$121K Buy
+18,708
New +$166K ﹤0.01% 1985
2024
Q3
– Sell
-10,828
Closed -$96.4K – 1496
2024
Q2
$96.4K Buy
+10,828
New +$104K ﹤0.01% 1297

Other funds holding VIR

Quantinno Capital Management's VIR Position: Q3 2026 in Review

Quantinno Capital Management reduced its Vir Biotechnology (VIR) stake by 9.1% in Q3 2026, selling an estimated $117K and leaving 116,229 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

Quantinno Capital Management first reported a position in VIR in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.3M in Q2 2026. 263 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Quantinno Capital Management held 116,229 shares of Vir Biotechnology worth $1.3M as of Q3 2026.
  • Quantinno Capital Management sold 11,696 Vir Biotechnology shares in Q3 2026, an estimated $117K.
  • Vir Biotechnology made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2567 holding.
  • Quantinno Capital Management first reported a position in Vir Biotechnology in Q2 2024 and has held it in 8 quarters since.
  • Quantinno Capital Management's Vir Biotechnology position peaked at $1.3M in Q2 2026.
  • 263 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.